Eagle Veterinary Technology Co.Ltd (044960) - Total Assets
Based on the latest financial reports, Eagle Veterinary Technology Co.Ltd (044960) holds total assets worth ₩67.78 Billion KRW (≈ $45.93 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Eagle Veterinary Technology Co.Ltd - Total Assets Trend (2014–2025)
This chart illustrates how Eagle Veterinary Technology Co.Ltd's total assets have evolved over time, based on quarterly financial data. Also see 044960 stock market capitalisation for the company's overall valuation and market capitalisation.
Eagle Veterinary Technology Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Eagle Veterinary Technology Co.Ltd's total assets of ₩67.78 Billion consist of 48.1% current assets and 51.9% non-current assets. Review 044960 current and long-term liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 7.1% |
| Accounts Receivable | ₩8.60 Billion | 13.5% |
| Inventory | ₩10.87 Billion | 17.0% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩198.63 Million | 0.3% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Eagle Veterinary Technology Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 044960 stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Eagle Veterinary Technology Co.Ltd's current assets represent 48.1% of total assets in 2025, an increase from 33.9% in 2014.
- Cash Position: Cash and equivalents constituted 7.1% of total assets in 2025, up from 6.9% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 17.0% of total assets.
Eagle Veterinary Technology Co.Ltd Competitors by Total Assets
Key competitors of Eagle Veterinary Technology Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Theragen Etex Co.Ltd
KQ:066700
|
Korea | ₩253.33 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩575.39 Billion |
|
ST Pharm Co.Ltd
KQ:237690
|
Korea | ₩782.57 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩222.34 Billion |
|
Mezzion Pharma Co.Ltd
KQ:140410
|
Korea | ₩98.92 Billion |
|
Komipharm International Co. Ltd
KQ:041960
|
Korea | ₩133.92 Billion |
|
Caregen Co.Ltd
KQ:214370
|
Korea | ₩233.98 Billion |
Eagle Veterinary Technology Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.67 | 3.31 | 3.74 |
| Quick Ratio | 2.46 | 2.04 | 2.35 |
| Cash Ratio | 0.00 | 0.00 | 0.25 |
| Working Capital | ₩25.77 Billion | ₩20.14 Billion | ₩18.20 Billion |
Eagle Veterinary Technology Co.Ltd - Advanced Valuation Insights
This section examines the relationship between Eagle Veterinary Technology Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.70 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 4.5% |
| Total Assets | ₩63.98 Billion |
| Market Capitalization | $26.69 Million USD |
Valuation Analysis
Below Book Valuation: The market values Eagle Veterinary Technology Co.Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Eagle Veterinary Technology Co.Ltd's assets grew by 4.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Eagle Veterinary Technology Co.Ltd (2014–2025)
The table below shows the annual total assets of Eagle Veterinary Technology Co.Ltd from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩63.98 Billion ≈ $43.36 Million |
+4.48% |
| 2024-12-31 | ₩61.24 Billion ≈ $41.50 Million |
+4.72% |
| 2023-12-31 | ₩58.48 Billion ≈ $39.63 Million |
+6.58% |
| 2022-12-31 | ₩54.87 Billion ≈ $37.18 Million |
+4.31% |
| 2021-12-31 | ₩52.60 Billion ≈ $35.65 Million |
+8.66% |
| 2020-12-31 | ₩48.41 Billion ≈ $32.81 Million |
+5.36% |
| 2019-12-31 | ₩45.94 Billion ≈ $31.14 Million |
-0.36% |
| 2018-12-31 | ₩46.11 Billion ≈ $31.25 Million |
-7.35% |
| 2017-12-31 | ₩49.77 Billion ≈ $33.73 Million |
+7.77% |
| 2016-12-31 | ₩46.18 Billion ≈ $31.30 Million |
+4.95% |
| 2015-12-31 | ₩44.00 Billion ≈ $29.82 Million |
+5.62% |
| 2014-12-31 | ₩41.66 Billion ≈ $28.23 Million |
-- |
About Eagle Veterinary Technology Co.Ltd
Eagle Veterinary Technology Co.,Ltd manufactures and sells animal health care products in South Korea. The company offers antibiotics, antibacterials, anthelmintics, antihistamins, and in the form of injectable, feed additives, oral liquids, and soluble powders for swine, poultry, and bovine. Eagle Veterinary Technology Co.,Ltd also exports its products to New Zealand, Australia, Vietnam, Kenya, … Read more